Royal Mail Plc (LON:RMG) Stock Rating Kept by Analysts at Liberum Capital; The GBX 370.00 Target Indicates -20.11% Potential; Eagle Test Systems (EGLT) Has 0.58 Sentiment

Egalet Corporation, a specialty pharmaceutical company, develops, makes, and commercializes treatments for patients with pain and other conditions. The company has market cap of $44.72 million. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It currently has negative earnings. The firm is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER.

Liberum Capital have a GBX 370.00 target on the stock. The target gives a potential downside of -20.11% from Royal Mail Plc (LON:RMG)‘s last stock close price. This rating was revealed to investors in an analyst report on Monday morning.

Among 19 analysts covering Royal Mail Plc (LON:RMG), 5 have Buy rating, 6 Sell and 8 Hold. Therefore 26% are positive. Royal Mail Plc has GBX 625 highest and GBX 300 lowest target. GBX 446.27’s average target is -2.05% below currents GBX 455.6 stock price. Royal Mail Plc had 152 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Royal Mail plc (LON:RMG) earned “Neutral” rating by Davy Research on Thursday, November 17. The firm has “Buy” rating by Beaufort Securities given on Friday, January 22. The firm has “Underperform” rating given on Tuesday, October 3 by Jefferies. The firm has “Hold” rating by HSBC given on Monday, January 23. Deutsche Bank maintained Royal Mail plc (LON:RMG) rating on Monday, February 1. Deutsche Bank has “Hold” rating and GBX 435 target. The stock has “Hold” rating by Cantor Fitzgerald on Wednesday, June 21. The stock has “Overweight” rating by Barclays Capital on Wednesday, February 17. As per Thursday, November 2, the company rating was maintained by JP Morgan. The rating was maintained by Barclays Capital on Monday, June 26 with “Overweight”. Barclays Capital maintained the shares of RMG in report on Wednesday, November 25 with “Equal Weight” rating.

Royal Mail plc operates as an universal postal service well-known provider in the United Kingdom and other European countries. The company has market cap of 4.56 billion GBP. It offers parcels and letter delivery services under the Royal Mail and Parcelforce Worldwide brands. It has a 12.73 P/E ratio. The firm also provides services for the collection, sorting, and delivery of parcels and letters; and creates and produces stamps and philatelic items, as well as offers media and marketing mail services.

The stock decreased 1.56% or GBX 7.2 during the last trading session, reaching GBX 455.6. About 512,960 shares traded. Royal Mail plc (LON:RMG) has 0.00% since January 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await Egalet Corporation (NASDAQ:EGLT) to report earnings on March, 8. They expect $-0.38 earnings per share, up 56.32% or $0.49 from last year’s $-0.87 per share. After $-0.46 actual earnings per share reported by Egalet Corporation for the previous quarter, Wall Street now forecasts -17.39% EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: